274 related articles for article (PubMed ID: 32674177)
1. [Treatment with Dexamethasone in Patients with COVID-19 - A Position Paper of the German Respiratory Society (DGP)].
Kolditz M; Dellweg D; Geerdes-Fenge H; Lepper PM; Schaberg T; Ewig S; Pfeifer M; Bauer T
Pneumologie; 2020 Aug; 74(8):493-495. PubMed ID: 32674177
[No Abstract] [Full Text] [Related]
2. [Recommendations for the Treatment of Elderly Patients with COVID-19 from the Taskforce for Gerontopneumology].
Stieglitz S; Frohnhofen H; Netzer N; Haidl P; Orth M; Schlesinger A
Pneumologie; 2020 Aug; 74(8):505-508. PubMed ID: 32434253
[No Abstract] [Full Text] [Related]
3. Dexamethasone: A boon for critically ill COVID-19 patients?
Patel SK; Saikumar G; Rana J; Dhama J; Yatoo MI; Tiwari R; Rodríguez-Morales AJ; Dhama K
Travel Med Infect Dis; 2020; 37():101844. PubMed ID: 32791213
[No Abstract] [Full Text] [Related]
4. Audio Interview: Tocilizumab and Covid-19.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Oct; 383(17):e114. PubMed ID: 33085870
[No Abstract] [Full Text] [Related]
5. Dexamethasone in the management of covid -19.
Johnson RM; Vinetz JM
BMJ; 2020 Jul; 370():m2648. PubMed ID: 32620554
[No Abstract] [Full Text] [Related]
6. Is the type of diabetes treatment relevant to outcome of COVID-19?
Bloomgarden Z
J Diabetes; 2020 Jul; 12(7):486-487. PubMed ID: 32353193
[No Abstract] [Full Text] [Related]
7. Audio Interview: Dexamethasone and Covid-19.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Jul; 383(4):e52. PubMed ID: 32706553
[No Abstract] [Full Text] [Related]
8. Dexamethasone nanomedicines for COVID-19.
Lammers T; Sofias AM; van der Meel R; Schiffelers R; Storm G; Tacke F; Koschmieder S; Brümmendorf TH; Kiessling F; Metselaar JM
Nat Nanotechnol; 2020 Aug; 15(8):622-624. PubMed ID: 32747742
[No Abstract] [Full Text] [Related]
9. Statins in coronavirus outbreak: It's time for experimental and clinical studies.
Bifulco M; Gazzerro P
Pharmacol Res; 2020 Jun; 156():104803. PubMed ID: 32289478
[No Abstract] [Full Text] [Related]
10. After 62 years of regulating immunity, dexamethasone meets COVID-19.
Cain DW; Cidlowski JA
Nat Rev Immunol; 2020 Oct; 20(10):587-588. PubMed ID: 32778829
[TBL] [Abstract][Full Text] [Related]
11. A Case of Coronavirus Disease 2019 Treated With Ciclesonide.
Nakajima K; Ogawa F; Sakai K; Uchiyama M; Oyama Y; Kato H; Takeuchi I
Mayo Clin Proc; 2020 Jun; 95(6):1296-1297. PubMed ID: 32402512
[No Abstract] [Full Text] [Related]
12. Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19.
DiNicolantonio JJ; Barroso J; McCarty M
Open Heart; 2020 Sep; 7(2):. PubMed ID: 32895293
[No Abstract] [Full Text] [Related]
13. Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring.
Favaloro EJ; Lippi G
Semin Thromb Hemost; 2020 Apr; 46(3):379-382. PubMed ID: 32279286
[No Abstract] [Full Text] [Related]
14. Audio Interview: Operation Warp Speed and Covid-19 Therapeutics.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Sep; 383(12):e92. PubMed ID: 32937059
[No Abstract] [Full Text] [Related]
15. Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome.
Chen LYC; Hoiland RL; Stukas S; Wellington CL; Sekhon MS
Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32883678
[TBL] [Abstract][Full Text] [Related]
16. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
Nisole S; Saulnier A; Gatignol A
Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
[No Abstract] [Full Text] [Related]
17. [Diagnosis and treatment of disease 2019 novel coronavirus infection suitable for Military support Hubei medical team].
Military Medical Expert Group on the Front-line
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):285-287. PubMed ID: 32294812
[TBL] [Abstract][Full Text] [Related]
18. Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Nov; 383(19):e123. PubMed ID: 33211936
[No Abstract] [Full Text] [Related]
19. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.
Tomazini BM; Maia IS; Cavalcanti AB; Berwanger O; Rosa RG; Veiga VC; Avezum A; Lopes RD; Bueno FR; Silva MVAO; Baldassare FP; Costa ELV; Moura RAB; Honorato MO; Costa AN; Damiani LP; Lisboa T; Kawano-Dourado L; Zampieri FG; Olivato GB; Righy C; Amendola CP; Roepke RML; Freitas DHM; Forte DN; Freitas FGR; Fernandes CCF; Melro LMG; Junior GFS; Morais DC; Zung S; Machado FR; Azevedo LCP;
JAMA; 2020 Oct; 324(13):1307-1316. PubMed ID: 32876695
[TBL] [Abstract][Full Text] [Related]
20. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective.
Halpin DMG; Singh D; Hadfield RM
Eur Respir J; 2020 May; 55(5):. PubMed ID: 32341100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
